Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes

International Journal of Hepatology

Volumn 2014, Issue , 2014, Pages

  Winther, Thilde Nordmann ^a   Jacobsen, Kari Stougaard ^a   Mirza, Aashiq Hussain ^a   Heiberg, Ida Louise ^a   Bang Berthelsen, Claus Heiner ^a   Pociot, Flemming ^a   Hogh, Birthe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; MICRORNA;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; BIOINFORMATICS; CHILD; CHRONIC HEPATITIS B; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE TARGETING; HOST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS;

EID: 84944784385     PISSN: 20903448     EISSN: 20903456     Source Type: Journal    
DOI: 10.1155/2014/791045     Document Type: Article

References (56)

1. M.-W. Yu, H.-C. Chang, Y.-F. Liaw et al., "Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives," Journal of the National Cancer Institute, vol. 92, no. 14, pp. 1159-1164, 2000.
2. Z. Luo, L. Li, and B. Ruan, "Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period," International Journal of Infectious Diseases, vol. 16, no. 2, pp. e82-e88, 2012.
3. Y.-F. Wei, G.-Y. Cui, P. Ye, J.-N. Chen, and H.-Y. Diao, "MicroRNAs may solve themystery of chronic hepatitis B virus infection," World Journal of Gastroenterology, vol. 19, no. 30, pp. 4867-4876, 2013.
4. T. N. Winther, C. H. Bang-Berthelsen, I. L. Heiberg, F. Pociot, and B. Hogh, "Differential plasma micro RNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B," PLoS ONE, vol. 8, no. 3, Article ID e58236, 2013.
5. E. M. Sokal, M. Paganelli, S. Wirth et al., "Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition," Journal of Hepatology, vol. 59, no. 4, pp. 814-829, 2013.
6. F. Bortolotti, M. Guido, S. Bartolacci et al., "Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study," Hepatology, vol. 43, no. 3, pp. 556-562, 2006.
7. R. Iorio, A. Giannattasio, F. Cirillo, L. D'Alessandro, and A. Vegnente, "Long-term outcome in children with chronic hepatitis B: a 24-year observation period," Clinical Infectious Diseases, vol. 45, no. 8, pp. 943-949, 2007.
8. Y.-H. Ni, M.-H. Chang, P.-J. Chen et al., "Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion," Gastroenterology, vol. 132, no. 7, pp. 2340-2345, 2007.
9. Y. Chen, A. Shen, P. J. Rider et al., "A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication," The FASEB Journal, vol. 25, no. 12, pp. 4511-4521, 2011.
10. R. M. O'Connell, D. S. Rao, A. A. Chaudhuri, and D. Baltimore, "Physiological and pathological roles for microRNAs in the immune system," Nature Reviews Immunology, vol. 10, no. 2, pp. 111-122, 2010.
11. M. Esteller, "Non-coding RNAs in human disease," Nature Reviews Genetics, vol. 12, no. 12, pp. 861-874, 2011.
12. Statens Serum Institut (SSI), Mandatory Notification Systems, SSI, Copenhagen, Denmark, 2013, http://www.ssi.dk/English/HealthdataandICT/Surveillance%20in%20Denmark/Mandatory% 20notification%20systems.aspx.
13. "EASL clinical practice guidelines: management of chronic hepatitis B virus infection," Journal of Hepatology, vol. 57, no. 1, pp. 167-185, 2012.
14. B. A. Haber, J. M. Block, M. M. Jonas et al., "Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B," Pediatrics, vol. 124, no. 5, pp. e1007-e1013, 2009.
15. A. S. F. Lok and B. J. McMahon, "Chronic hepatitis B: update of recommendations," Hepatology, vol. 39, no. 3, pp. 857-861, 2004.
16. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2- ΔΔCT method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
17. J.-H. Yang, J.-H. Li, P. Shao, H. Zhou, Y.-Q. Chen, and L.- H. Qu, "StarBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data," Nucleic Acids Research, vol. 39, no. 1, pp. D202-D209, 2011.
18. X. Liu, X. Yu, D. J. Zack, H. Zhu, and J. Qian, "TiGER: a database for tissue-specific gene expression and regulation," BMC Bioinformatics, vol. 9, article 271, 2008.
19. S.-J. Xiao, C. Zhang, Q. Zou, and Z.-L. Ji, "TiSGeD: a database for tissue-specific genes," Bioinformatics, vol. 26, no. 9, Article ID btq109, pp. 1273-1275, 2010.
20. T. N. Winther, I. L. Heiberg, C. H. Bang-Berthelsen, F. Pociot, and B. Hogh, "Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children," PLoS ONE, vol. 8, no. 11, Article ID e80384, 2013.
21. H.-T. Zhu, Q.-Z. Dong, G. Wang et al., "Identificationof suitable reference genes for qRT-PCR analysis of circulatingmicroRNAs in hepatitis B virus-infected patients," Molecular Biotechnology, vol. 50, no. 1, pp. 49-56, 2012.
22. J. Vandesompele, K. De Preter, F. Pattyn et al., "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes," Genome Biology, vol. 3, no. 7, 2002.
23. G. Amaddeo, C. Guichard, S. Imbeaud, and J. Zucman-Rossi, "Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors," Onco Immunology, vol. 1, no. 9, pp. 1612-1613, 2012.
24. J. Huang, Q. Deng, Q. Wang et al., "Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma," Nature Genetics, vol. 44, no. 10, pp. 1117-1121, 2012.
25. T. Saitoh, J. Moriwaki, J. Koike et al., "Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway," Biochemical and Biophysical Research Communications, vol. 281, no. 3, pp. 815-820, 2001.
26. J. Dudas, T. Mansuroglu, F. Moriconi et al., "Altered regulation of Prox1-gene-expression in liver tumors," BMC Cancer, vol. 8, article 92, 2008.
27. Q. Feng, J. E. Stern, S. E. Hawes, H. Lu, M. Jiang, and N. B. Kiviat, "DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection," Experimental and Molecular Pathology, vol. 88, no. 2, pp. 287-292, 2010.
28. N. Trehanpati, S. Shrivastav, B. Shivakumar et al., "Analysis of Notch and TGF-β signaling expression in different stages of disease progression during hepatitis B virus infection," Clinical and Translational Gastroenterology, vol. 3, article e23, 2012.
29. L. Yao, F.-J. Li, Z.-Q. Tang, S. Gao, and D.-Q. Wu, "Smad4 expression in hepatocellular carcinoma differs by hepatitis status," Asian Pacific Journal of Cancer Prevention, vol. 13, no. 4, pp. 1297-1303, 2012.
30. E. A. Conner, E. R. Lemmer, M. Omori, P. J. Wirth, V. M. Factor, and S. S. Thorgeirsson, "Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis," Oncogene, vol. 19, no. 44, pp. 5054-5062, 2000.
31. K. Takahashi, N. Ikeda, N. Nonoguchi et al., "Enhanced expression of coproporphyrinogen oxidase inmalignant brain tumors: CPOX expression and 5-ALA-induced fluorescence," Neuro-Oncology, vol. 13, no. 11, pp. 1234-1243, 2011.
32. F. Shen, J. Li, W. Cai et al., "GATA6 predicts prognosis and hepatic metastasis of colorectal cancer," Oncology Reports, vol. 30, no. 3, pp. 1355-1361, 2013.
33. T. Heise, G. Sommer, K. Reumann, I. Meyer, H. Will, and H. Schaal, "Thehepatitis B virus PRE contains a splicing regulatory element," Nucleic Acids Research, vol. 34, no. 1, pp. 353-363, 2006.
34. Y.-H. Ou, P.-H. Chung, F.-F. Hsu, T.-P. Sun, W.-Y. Chang, and S.-Y. Shieh, "The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1," The EMBO Journal, vol. 26, no. 17, pp. 3968-3980, 2007.
35. P. Landgraf, M. Rusu, R. Sheridan et al., "A mammalian micro-RNA expression atlas based on small RNA library sequencing," Cell, vol. 129, no. 7, pp. 1401-1414, 2007.
36. Z. Li, X. Gu, Y. Fang, J. Xiang, and Z. Chen, "microRNA expression profiles in human colorectal cancers with brain metastases," Oncology Letters, vol. 3, no. 2, pp. 346-350, 2012.
37. H. Xie, L. Lee, S. Caramuta et al., "MicroRNA expression patterns related tomerkel cell polyomavirus infection in human Merkel cell carcinoma," The Journal of Investigative Dermatology, vol. 134, no. 2, pp. 507-517, 2014.
38. A. Markou, I. Sourvinou, P. A. Vorkas, G. M. Yousef, and E. Lianidou, "Clinical evaluation of microRNA expression profiling in non small cell lung cancer," Lung Cancer, vol. 81, no. 3, pp. 388-396, 2013.
39. L. Li, Z. Guo, J. Wang, Y. Mao, and Q. Gao, "Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening," Digestive Diseases and Sciences, vol. 57, no. 11, pp. 2910-2916, 2012.
40. J. Gui, Y. Tian, X. Wen et al., "Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies," Clinical Science, vol. 120, no. 5, pp. 183-193, 2011.
41. X.-M. Zhu, L.-J. Wu, J. Xu, R. Yang, and F.-S. Wu, "Let-7c MicroRNA expression and clinical significance in hepatocellular carcinoma," Journal of International Medical Research, vol. 39, no. 6, pp. 2323-2329, 2011.
42. H.-Y. Jia, Y.-X. Wang, W.-T. Yan et al., "MicroRNA-125b functions as a tumor suppressor in hepatocellular carcinoma cells," International Journal of Molecular Sciences, vol. 13, no. 7, pp. 8762-8774, 2012.
43. C. Xu, S. Liu, H. Fu et al., "MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells," European Journal of Cancer, vol. 46, no. 15, pp. 2828-2836, 2010.
44. S.-M. Kang, H.-J. Lee, and J.-Y. Cho, "MicroRNA-365 regulates NKX2-1, a keymediator of lung cancer," Cancer Letters, vol. 335, no. 2, pp. 487-494, 2013.
45. S. Shimizu, T. Takehara, H. Hikita et al., "The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma," Journal of Hepatology, vol. 52, no. 5, pp. 698-704, 2010.
46. L. Zeng, J. Yu, T. Huang et al., "Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma," BMC Genomics, vol. 13, supplement 8, article S14, 2012.
47. A. Fujimoto, Y. Totoki, T. Abe et al., "Whole-genome sequencing of liver cancers identifies etiological influences onmutation patterns and recurrent mutations in chromatin regulators," Nature Genetics, vol. 44, no. 7, pp. 760-764, 2012.
48. S. A. Bossone, C. Asselin, A. J. Patel, and K. B. Marcu, "MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 16, pp. 7452-7456, 1992.
49. N. G. Nagl Jr., D. R. Zweitzig, B. Thimmapaya, G. R. Beck Jr., and E. Moran, "The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest," Cancer Research, vol. 66, no. 3, pp. 1289-1293, 2006.
50. M. Bechard, R. Trost, A. M. Singh, and S. Dalton, "Frat is a phosphatidylinositol 3-kinase/akt-regulated determinant of glycogen synthase kinase 3β subcellular localization in pluripotent cells," Molecular and Cellular Biology, vol. 32, no. 2, pp. 288-296, 2012.
51. C. Coulouarn, L. E. Gomez-Quiroz, J.-S. Lee et al., "Oncogenespecific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis," Hepatology, vol. 44, no. 4, pp. 1003-1011, 2006.
52. L. Song, H. Liu, S. Gao, W. Jiang, and W. Huang, "Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells," Journal of Virology, vol. 84, no. 17, pp. 8849-8860, 2010.
53. A. Formosa, E. K. Markert, A. M. Lena et al., "MicroRNAs, miR- 154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR- 487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells," Oncogene, vol. 33, pp. 5173-5182, 2014.
54. S. Taketani, T. Furukawa, and K. Furuyama, "Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells," European Journal of Biochemistry/FEBS, vol. 268, no. 6, pp. 1705-1711, 2001.
55. M. Corioni, N. Antih, G. Tanackovic, M. Zavolan, and A. Krämer, "Analysis of in situ pre-mRNA targets of human splicing factor SF1 reveals a function in alternative splicing," Nucleic Acids Research, vol. 39, no. 5, pp. 1868-1879, 2011.
56. H. L. Janssen, H. W. Reesink, E. J. Lawitz et al., "Treatment of HCV infection by targeting microRNA," The New England Journal of Medicine, vol. 368, no. 18, pp. 1685-1694, 2013.